Generic drugs product development

•

29 likes•4,601 views

Bashant Kumar sah

This is the written note on the topic of generic drug product development.in regulatory affairs subject

Health & Medicine

What's hot

hatch-waxman act@amendments

Bharati vidyapeeth college of pharmacy, kolhapur

Supac

sonianagvenkar

Scale up and post approval changes(supac)

bdvfgbdhg

Outsourcing BA and BE to CRO

Institute of Pharmaceutical Education and Research

Quality by Design ( QbD )

Navaneethakrishnan Palaniappan

ANDA regulatory approval process

ROHIT

Biowaivers

Institute of Pharmacy, Nirma University

Code of Federal Regulations

Swapnil Fernandes

Investigation of medicinal product dossier (IMPD)

Himal Barakoti

Global Subbmission of IND, NDA, ANDA

Maruthi.N

DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...

deepalisanap31

Cmc, post approval and regulation

Himal Barakoti

Developing clinical trial protocols,institutional review board(irb,iec),infor...

Bashant Kumar sah

Distribution records

JyotiMhoprekar

 DRUG MASTER FILE  Presented by :  RUSHIKESH D MENDHE  Roll no - 511  Mpharm Ist Year  (Department of Pharmaceutics)  Content : :  INTRODUCTION  TYPES OF DMF  DMF FORMAT & ASSEMBLY  DELIVERY OF DMF TO FDA  SUBMISSION OF DMF  THE MECHANISM OF A DRUG MASTER FILE  CTD & ELECTRONIC DMFS  UPDATES TO DMF  CLOSURE OF A DRUG MASTER FILE  APPLICATION OF DMF  REFERENCE  INTRODUCTION :  A Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA) that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.  This guideline does not impose mandatory requirements.  Objectives :  Main Objective of the DMF is to support regulatory requirements  To prove the quality, safety and efficacy of the medicinal product  TYPES OF DMF :  DMF FORMAT & ASSEMBLY :  The DMF is submitted as Original and Duplicate jackets, collated, assembled, paginated, and jacketed, using covers obtained from the government printing office and a respecifically provided for the DMFs  Multiple volumes are numbered, and the paper must be standard paper size  Paper length should not be less than 10 inches nor more than 12 inches.  Each volume of a DMF should be not more than 2 inches thick  DELIVERY OF DMF TO FDA :  DMF should be submitted at following address :  Food and Drug Administration Center for Drug Evaluation and Research Central Document Room 5901 – B Ammendale Road Beltsville, MARYLAND 20705-1266 USA  SUBMISSION OF DMF :  The DMF must be submitted in two copies, one with a blue cover and one with a red cover.  Each page of each copy of the DMF should be dated and consecutively numbered.  Each DMF submission should contain : • A Transmittal letter • Administrative information about the submission • Other specific information A. Transmittal Letter : i) Original Submissions : • Identification of submission: Original, the type of DMF as classified in Section III, and its subject. • Identification of the applications, if known, that the DMF is intended to support, including the name and address of each sponsor, applicant, or holder, and all relevant document numbers. • Signature of the holder or the authorized representative. • Typewritten name and title of the signer. ii) Ammendments : • Identification of submission: Amendment, the DMF number, type of DMF, and the subject of the amendment. • A description of the purpose of submission, e.g., update, revised formula, or revised process. • Signature of the holder or the authorized representative. • Typewritten name and title of the signer. B. Administrative information about the submission:

DMF Drug Master File

Rushi Mendhe

Drug master file (DMF)

Bashant Kumar sah

Pharmacovigilance safety Mon. in clinical trials.pptx

Roshan Yadav

Hippa new requirement to clinical study processes

Kavya S

cmc [ chemistry manufacturing control ]

Akshay Patil

Objectives and policies of cGMP & Inventory management and control

Arul Packiadhas

What's hot (20)

hatch-waxman act@amendments

Supac

Scale up and post approval changes(supac)

Outsourcing BA and BE to CRO

Quality by Design ( QbD )

ANDA regulatory approval process

Biowaivers

Code of Federal Regulations

Investigation of medicinal product dossier (IMPD)

Global Subbmission of IND, NDA, ANDA

DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...

Cmc, post approval and regulation

Developing clinical trial protocols,institutional review board(irb,iec),infor...

Distribution records

DMF Drug Master File

Drug master file (DMF)

Pharmacovigilance safety Mon. in clinical trials.pptx

Hippa new requirement to clinical study processes

cmc [ chemistry manufacturing control ]

Objectives and policies of cGMP & Inventory management and control

Recently uploaded

Thoracotomy is the surgical procedure with an incision made to access the pleural space and the contents of the thoracic cavity. Given the structures to be accessed with in the cavity, different incisions have been established to easy the procedure and these incisions qualify the types of thoracotomies to be studied hereunder. PRE OP OPTIMIZATION FOR SPECIFIC FACTORS The outcome of surgical procedures is not measured only by clinical end points but also shorter stays and lower costs. Patients’ discharge is delayed commonly due to inadequate pain relief, infection, arrhythmias, prolonged air leak and debility. Many complications that occur from thoracic operations can be anticipated. An aggressive preoperative work up mitigates morbidity and shortens convalescence. APPROACH CONSIDERATIONS There are about three principles that can guides the choice of the thoracotomy incision to be used I. Adequate exposure must be achieved. The choice of incision is aided by a thorough understanding of the surface anatomy and a comprehensive review of the radiographic images that are obtained preoperatively. II. Chest-wall function and appearance should be preserved to the extent possible. This principle include non-spreading video-assisted thoracoscopic surgery (VATS) procedures, muscle-sparing techniques, avoidance of excessive rib retraction, and rib preservation when possible. III. The third principle is that closure must be meticulous and appropriate. Strict layered closure is the rule for thoracic surgical incisions. Every effort should be made to approximate the individual divided chest-wall muscles in appropriate layers; otherwise, a significant delay in the recovery of range of motion (ROM) may result. Care must be taken to avoid over approximating the ribs and to prevent an override; this will help minimize postoperative pain. POST-OPERATIVE CARE AND MONITORING

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1

DR SETH JOTHAM

Retinal consideration in cataract surgery

KafrELShiekh University

Fundamental of Radiobiology -SABBU.pptx

Sabbu Khatoon

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

Prix Galien International 2024 Forum Program

Levi Shapiro

Compare home pulse pressure components collected directly from home

Catherine Liao

TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...

kevinkariuki227

Gauri Gawande(9) Constipation Final.pptx

gauripg8

Arterial health throughout cancer treatment and exercise rehabilitation in wo...

Catherine Liao

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

Contact dermaititis (irritant and allergic).pdf

Chulalongkorn Allergy and Clinical Immunology Research Group

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

Bright Chipili

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

drwaque

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

gauripg8

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx

Dr KHALID B.M

Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)

Dr. Aryan (Anish Dhakal)

Anti ulcer drugs and their Advance pharmacology || Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining. ||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.

Antiulcer drugs Advance Pharmacology .pptx

Rohit chaurpagar

Linearity concept of significance, standard deviation, chi square test, students T- test, ANOVA test , pharmaceutical science, statistical analysis, statistical methods, optimization technique, modern pharmaceutics, pharmaceutics, mpharm 1 unit i sem, 1 year m pharm, applications of chi square test, application of standard deviation , pharmacy, method to compare dissolution profile, statistical analysis of dissolution profile, important statical analysis, m. pharmacy, graphical representation of standard deviation, graph of chi square test, graph of T test , graph of ANOVA test ,formulation of t test, formulation of chi square test, formula of standard deviation.

linearity concept of significance, standard deviation, chi square test, stude...

KavyasriPuttamreddy

Scientificity and feasibility study of non-invasive central arterial pressure...

Catherine Liao

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Catherine Liao

Anuman- An inference for helpful in diagnosis and treatment

abdeli bhadarva

Recently uploaded (20)

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1

Retinal consideration in cataract surgery

Fundamental of Radiobiology -SABBU.pptx

Prix Galien International 2024 Forum Program

Compare home pulse pressure components collected directly from home

TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...

Gauri Gawande(9) Constipation Final.pptx

Arterial health throughout cancer treatment and exercise rehabilitation in wo...

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Contact dermaititis (irritant and allergic).pdf

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx

Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)

Antiulcer drugs Advance Pharmacology .pptx

linearity concept of significance, standard deviation, chi square test, stude...

Scientificity and feasibility study of non-invasive central arterial pressure...

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Anuman- An inference for helpful in diagnosis and treatment